Top 10 Private Equity Investors in Medical Industry in the World in 2021 by Deal Volume
Casdin Capital LLC, Hellman & Friedman LLC, First Light Asset Management, LLC, Orbimed Advisors LLC, and Perceptive Advisors LLC are among the top 5 private equity investors in the medical industry in 2021 by deal volume. In terms of the geographic split, 8 out of the world’s top 10 private equity investors in the medical industry are headquartered in North America, whereas the remaining 2 are based in Europe. They employed a total of 1,471 people in 2021. The Samlyn Capital-Satsuma Pharmaceuticals deal was one of the major deals in the medical sector in 2021. SVB Securities LLC served as exclusive financial advisor to Satsuma Pharmaceuticals Inc. Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel therapeutic product candidate for the acute treatment of migraine, has announced that it has agreed to sell 14,084,507 shares of its common stock to certain institutional investors in private investment in public equity (PIPE) financing at an offering price of $5.68 per share, to raise gross proceeds of $80 million. The deal was completed in Q1 2021. The TPG-Caris Life Sciences deal was another major deal in the medical sector in 2021. Shearman & Sterling LLP served as legal advisors to Caris Life Sciences Inc. Caris Life Sciences, an innovator in molecular science and artificial intelligence (AI) focused on fulfilling the promise of precision medicine, announced an $830 million growth equity round at a post-money valuation of $7.83 billion. The deal was completed in Q2 2021. The EQT-Lifebrain deal was another major deal in the medical sector in 2021. Ernst & Young Global Ltd served as financial advisor to EQT, while Orrick, Herrington, and Sutcliffe LLP served as legal advisor to EQT. EQT Partners AB, a private equity firm, has agreed to acquire Lifebrain, a company engaged in laboratory medicine for patients, from Investindustrial, a private equity firm, for a purchase consideration of EUR1 billion. The deal was completed in Q4 2021.